AIDS vaccine

AIDS vaccine

A hypothetical vaccine intended to either prevent HIV infection or ensure that those infected will not fall victim to AIDS; the most promising vaccine is that using a naked DNA plasmid, reported by Letwin et al in 20/10/00 Science; as of early 2001, there is no effective vaccine. See gp160 vaccine, HGP-30, HIV, V3 loop, Zagury.
References in periodicals archive ?
The new method represents an important platform for AIDS vaccine discovery, says Rich Wyatt, senior director, viral immunology, at IAVI's Neutralizing Antibody Center (NAC) at The Scripps Research Institute(TSRI) in La Jolla, CA.
GeoVax's AIDS vaccine technology is exclusively licensed from Emory University in Atlanta, GA, and is the subject of more than 20 issued or filed patent applications.
London, Aug 8 (ANI): Focussing their research on simian immunodeficiency viruses (SIVs) in African nonhuman primates, scientists at the Yerkes National Primate Research Center, Emory University, have proposed an additional new approach to the AIDS vaccine research agenda in a commentary.
GeoVax's AIDS vaccine technology is the subject of 20 issued or filed patent applications.
MEXICO CITY -- The development of an AIDS vaccine is likely to take a long time, and research needs to be more selectively focused on the most promising candidate vaccines, given the recent failure of the latest leading candidate to prevent infection in a large, international trial, according to the findings of a report aimed at setting priorities for AIDS vaccine research.
MEXICO CITY -- The development of an AIDS vaccine is likely to take a long time, and research needs to be more selectively focused on the most promising candidate vaccines, given the recent failure of the latest leading candidate to prevent infection in a large international trial, according to the findings of a report aimed at setting priorities for AIDS vaccine research.
The International AIDS Vaccine Initiative (IAVI) and Key Thought Leaders Explore Critical Next Steps for AIDS Vaccine Research at the 17th International AIDS Conference in Mexico City
This review highlights the extensive preparedness activities undertaken from 2002 by the International AIDS Vaccine Initiative (IAVI), its Indian government and non government partners with the Indian scientific, political, media and community stakeholders and the capacity building process, before the conduct of the first ever AIDS vaccine trials in India in early 2005.
OTC BB:GOVX), an Atlanta based biotechnology company, has announced receipt of an estimated $15,000,000 Integrated Preclinical/Clinical AIDS Vaccine Development [IPCAVD] Grant to support its HIV/AIDS vaccine program.
Ending AIDS: The Search for a Vaccine", an excellent 56-minute documentary history of AIDS vaccine research narrated by Richard Gere, will be shown on PBS in December 2005; check local stations for scheduled times.
Three years ago Mark Moreau, a young gay New York actor, saw an ad seeking volunteers for the first full-scale trial of an AIDS vaccine.
On February 24 researchers announced the results of an extensive trial for a possible AIDS vaccine.

Full browser ?